Treatment of Resistant Depression: A Pilot Study Assessing the Efficacy of a tDCS-Mindfulness Program Compared With a tDCS-Relaxation Program.

Author: Monnart A1, Vanderhasselt MA2,3, Schroder E1, Campanella S1, Fontaine P4, Kornreich C1
Affiliation: <sup>1</sup>Laboratory of Psychological Medicine and Addictology, CHU Brugmann - ULB Neuroscience Institue (UNI), University of Brussels (ULB), Brussels, Belgium. <sup>2</sup>Department of Head and Skin, Ghent Experimental Psychiatry Lab, Ghent University (UGent), Ghent, Belgium. <sup>3</sup>Department of Experimental Clinical and Health Psychology, Ghent University, Ghent, Belgium. <sup>4</sup>Department of Psychiatry, CHU de Charleroi, Charleroi, Belgium.
Conference/Journal: Front Psychiatry.
Date published: 2019 Oct 23
Other: Volume ID: 10 , Pages: 730 , Special Notes: doi: 10.3389/fpsyt.2019.00730. eCollection 2019. , Word Count: 259


Background: This pilot study explores a therapeutic setting combining transcranial direct current stimulation (tDCS) and mindfulness-based cognitive therapy (MBCT) for patients with drug-resistant depression. tDCS has shown efficacy for depression treatment and improvement could be maintained with the combination with mindfulness, which has shown depression relapse-prevention properties. Methods: Thirty-one treatment-resistant depressed patients have been assigned to our experimental treatment condition [tDCS combined with MBCT (n = 15)] or to a control condition [tDCS combined with relaxation (n = 16)]. Patients have completed both an intensive treatment block (eight consecutive days) and a single remind session 2 weeks after the intensive treatment. Clinical (depression, anxiety, and rumination) and cognitive (general cognitive functioning, mental flexibility, and working memory) symptoms of depression have been assessed through different questionnaires at baseline (t0), after the first block of treatment (t1), and after the remind session (t2). Results: Results seem to indicate a positive impact of both treatment conditions on clinical and cognitive symptoms of depression at t1. However, the treatment condition combining tDCS with mindfulness has been found to better maintain clinical improvements at t2 regarding some clinical [Montgomery-Åsberg Depression Rating Scale (MADRS) and Sadness and Anger Ruminative Inventory (SARI)] and cognitive variables (Digit Span-F and Digit Span-B). Conclusion: Based on the current observations, a multi-disciplinary treatment approach combining tDCS and MBCT might be effective in resistant depressed patients in the long run, even though further clinical research is necessary.

Copyright © 2019 Monnart, Vanderhasselt, Schroder, Campanella, Fontaine and Kornreich.

KEYWORDS: cognitive control; major depressive disorder; mindfulness-based cognitive therapy; rumination; transcranial direct current stimulation (tDCS)

PMID: 31708808 PMCID: PMC6819945 DOI: 10.3389/fpsyt.2019.00730